

Huntington’s disease in children is a rare and complex genetic disorder that affects the nervous system and shows symptoms at an early age. Early detection helps parents and doctors manage the condition more effectively, reduce complications, and improve the child’s quality of life.
In this article on Dalili Medical, we’ll cover:
The early symptoms of Huntington’s disease in children
Accurate diagnostic methods
Potential risks and complications
The latest treatment options and available support
If you have a child or know someone at risk, this article will be your complete guide to understanding the condition and taking the right steps at the right time.
Juvenile Huntington’s disease is a rare form of Huntington’s that appears before the age of 20. It affects movement, thinking, and behavior in children and adolescents, making early monitoring and medical follow-up extremely important.
Yes. Huntington’s disease is genetic and linked to the HTT gene. It usually follows an autosomal dominant pattern, meaning a child only needs one copy of the mutated gene to develop the disease.
Involuntary movements or body tremors
Learning delays or difficulty focusing in school
Mood changes or behavioral problems
Poor motor control or difficulty walking
Clinical examination to observe motor and behavioral symptoms
Genetic testing to confirm the presence of the HTT gene mutation
Brain imaging tests (in some cases) to track any neurological damage
Unfortunately, there is no complete cure. However, symptoms can be managed through:
Medications to reduce involuntary movements or psychiatric problems
Educational and rehabilitation support for children
Physical therapy to improve movement and balance
With early intervention and continuous support, children can have a better quality of life and participate in daily activities. However, family support is usually essential in most cases.
Yes. Genetic testing is very important, as it confirms the diagnosis and helps families understand the risk of passing the disease to other children.
Having a family history of the disease
Carrying the HTT gene mutation
Juvenile Huntington’s disease (JHD) is a very rare inherited condition that begins before age 20. Its primary cause is a mutation in the HTT gene, which produces the huntingtin protein.
Located on chromosome 4
Normally, the gene contains a limited number of CAG repeats
If the repeats exceed 40 or more, the disease develops
The higher the number of repeats, the earlier and more severe the symptoms appear
JHD is inherited in an autosomal dominant pattern, meaning a child has a 50% chance of inheriting the disorder if one parent carries the defective gene
Research shows that cases appearing in childhood often come from the father, due to a phenomenon called genetic anticipation (where the CAG repeats expand further in the next generation)
Genetic anticipation means that when the defective gene is passed from the father, the number of CAG repeats may expand, leading to earlier onset and more severe symptoms.
This is why Juvenile Huntington’s Disease (JHD) is more common in children whose father is affected.
The symptoms usually appear before the age of 20 and mainly affect movement, learning, and behavior. They differ from the classical adult form.
Muscle stiffness or rigidity (instead of chorea, which is more common in adults).
Difficulty walking and maintaining balance → the child may stumble or fall easily.
Slow and uncoordinated movements.
Muscle weakness and poor hand-eye coordination.
Learning delays or decline in school performance.
Difficulty maintaining focus and attention for long periods.
Memory problems, especially with new information.
Slower information processing and problem-solving.
Sudden mood swings such as intense anger or sadness.
Aggressive or withdrawn behavior.
Trouble socializing or interacting with peers.
Signs of depression or persistent anxiety in some cases.
Unexplained weight loss or appetite changes.
Sleep disturbances.
Delays in developing daily life skills (eating, dressing, writing).
Early motor signs: hand tremors or slowness in fine movements.
Early behavioral or academic difficulties: poor focus, mood changes, social challenges.
Some children develop muscle spasms or walking difficulties.
Worsening motor problems: balance issues, walking difficulties, more frequent spasms.
Increasing academic and behavioral struggles: learning difficulties, temper outbursts, poor peer relationships.
Speech problems may begin: slowed speech, difficulty expressing ideas.
More pronounced motor decline: tremors, poor muscle control, unstable walking.
Noticeable cognitive and behavioral deterioration: significant learning difficulties, impaired social interactions.
Some children require full support in daily activities.
Severe motor and coordination problems.
Complete dependence on caregivers for daily activities.
Severe behavioral and emotional challenges, with possible anxiety or depression.
Involuntary movements (chorea) affecting walking and sitting.
Muscle spasms causing difficulty with everyday movement.
Poor control of hands and feet during play or writing.
Gradual intellectual decline as the disease progresses.
Difficulty focusing in school.
Learning delays and struggles with complex daily tasks.
Severe mood swings (depression, anxiety).
Social withdrawal or aggressive behaviors.
Impaired communication and social interaction skills.
Weight loss and nutrition problems due to eating difficulties and involuntary movements.
Sleep problems linked to overactive nerves or anxiety.
Other neurological or motor-related health problems such as joint pain or muscle weakness.
Ongoing dependence on family for daily care.
Difficulty participating in school or group play.
Need for continuous medical follow-up and rehabilitation to reduce the disease’s impact on quality of life.
The most important step since JHD is hereditary.
The doctor will ask about developmental delays, motor issues, learning difficulties, or unusual behaviors.
Motor and balance assessment: checking for tremors, stiffness, or walking problems.
Cognitive and behavioral evaluation: focus, learning ability, and social interactions.
Other body functions assessed depending on presenting symptoms.
Assessment of the nervous system to detect any damage or problems in the nerves and movement.
Sometimes an MRI scan is performed to observe brain changes, especially in the basal ganglia area.
The most accurate and definitive method of diagnosis.
HTT gene analysis is done to identify the number of CAG repeats that cause the disease.
Testing can be performed in children if there is a known family history, helping to confirm the diagnosis with almost 100% accuracy.
Assessing cognitive and learning abilities to determine the child’s level and the type of support needed.
Monitoring social and emotional behaviors to see if early psychological or social intervention is required.
After diagnosis, a regular follow-up plan is essential to track the progression of symptoms:
Motor skills and balance.
Cognitive and behavioral development.
Psychological and social support.
Family History of the Disease
The most important risk factor.
If one parent is affected or carries the HTT gene mutation, the child is at risk.
Genetic Inheritance
The disease is autosomal dominant, meaning a single copy of the defective gene is enough to cause the condition.
Each pregnancy from an affected parent carries a 50% chance of passing on the mutation.
Number of CAG Repeats in the HTT Gene
The higher the number of CAG repeats, the earlier and more severe the symptoms.
Children with very large repeat expansions may show symptoms in early childhood or adolescence.
Extended Family History
Having multiple relatives affected increases the likelihood of earlier recognition and diagnosis.
Lack of Early Screening or Genetic Testing
Without early detection, it becomes harder to intervene promptly and provide proper support.
There is no cure for Huntington’s disease, as it is a progressive genetic neurodegenerative disorder.
The goal of medication is to manage symptoms and improve the child’s quality of life.
Treatment is usually part of a comprehensive care plan, including physical therapy, psychological support, and rehabilitation.
Goal: Reduce involuntary movements and tremors.
Tetrabenazine: Decreases dopamine release and helps reduce abnormal movements.
Haloperidol (or Droperidol-like drugs): Sometimes used in severe cases or when aggressive behavior is present.
⚠️ Note: Side effects like drowsiness or depression should be carefully monitored.
Goal: Manage anxiety, depression, aggression, or irritability.
Common medications:
Antidepressants (SSRIs such as Fluoxetine): For depression and anxiety.
Sedatives or antipsychotics (such as Risperidone): To control aggression or behavioral disorders.
Notes: Dosing must be carefully adjusted based on the child’s age and weight.
Goal: Help the child with learning and reduce hyperactivity.
Common medications:
Stimulants such as Methylphenidate: Sometimes used if ADHD symptoms are present.
Notes: Should be prescribed cautiously, as not all children are suitable candidates.
Goal: Improve sleep disturbances caused by involuntary movements or anxiety.
Common medications:
Melatonin: A mild sleep aid under medical supervision.
Feeding and digestion problems: Support for children with swallowing difficulties or loss of appetite.
Muscle spasms: Muscle relaxants may be prescribed in some cases.
Surgery is not a cure
Since Huntington’s is a genetic neurodegenerative condition, surgery cannot remove the cause or stop disease progression.
Surgical options are only considered for severe symptoms that don’t respond to medications or physical therapy.
Deep Brain Stimulation (DBS)
What is it? A small device implanted in targeted brain areas to regulate involuntary movements (chorea).
Goal: Reduce tremors and uncontrolled movements that disrupt daily life.
Advantages:
Adjustable electrical signals tailored to the child’s needs.
Improves motor control and may reduce reliance on medications.
Notes:
Not suitable for all children; requires careful evaluation by a neurologist and neurosurgeon.
Possible risks include bleeding, infection, or device-related complications.
Other supportive surgical interventions
Rarely, procedures to address severe spasms or brain nodules may be considered, but only in very specific cases.
Most children rely primarily on medications and rehabilitative therapies, with surgery being a very limited option.
Juvenile Huntington’s is a progressive genetic neurological disorder. While there is no cure, early intervention and continuous support can significantly improve the child’s quality of life and daily participation.
Regular follow-ups with a neurologist to monitor disease progression.
Adjusting medications based on motor and psychological symptoms.
Genetic and brain imaging assessments as recommended.
Exercises to strengthen muscles and improve balance.
Training to support walking, writing, and daily activities.
Use of assistive devices such as walkers or wheelchairs when needed.
Counseling sessions to manage anxiety and depression.
Strategies to cope with mood swings and aggressive behavior.
Social programs to encourage interaction with peers.
Customized learning plans tailored to the child’s abilities.
Support with focus, attention, and school performance.
Teaching essential life skills such as eating, dressing, and personal hygiene.
Training parents to handle daily symptoms and assist with routines.
Involving families in medical and rehabilitation decisions.
Joining family support groups to share experiences and guidance.
Establishing a consistent daily routine to provide stability.
Safe physical activities to maintain mobility and balance.
Prioritizing healthy sleep patterns and balanced nutrition to minimize complications.